Citadel Advisors’s Biomea Fusion BMEA Stock Holding History
Bought
Maintained
Sold
Other funds holding BMEA
ACM
FISPB
Citadel Advisors's BMEA Position: Q2 2026 in Review
Citadel Advisors reduced its Biomea Fusion (BMEA) stake by 93% in Q2 2026, selling an estimated $913K and leaving 44,916 shares worth $66K. The position accounts for ﹤0.01% of the portfolio, ranked #12975.
Citadel Advisors first reported a position in BMEA in Q2 2021 and has held it in 17 quarters since. The position peaked at $4.02M in Q2 2022. 61 funds tracked by Wall St. Rank hold BMEA as of Q2 2026.
- Citadel Advisors held 44,916 shares of Biomea Fusion worth $66K as of Q2 2026.
- Citadel Advisors sold 611,901 Biomea Fusion shares in Q2 2026, an estimated $913K.
- Biomea Fusion made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12975 holding.
- Citadel Advisors first reported a position in Biomea Fusion in Q2 2021 and has held it in 17 quarters since.
- Citadel Advisors's Biomea Fusion position peaked at $4.02M in Q2 2022.
- 61 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.